CAJ - Capitol Health

[Gringotts Bank]

Radiology usage is shrinking massively.

Research on the usefulness of diagnostic imaging is overwhelmingly negative. That is, it's not useful for most patient conditions most of the time. Of course there are still exceptions, but the imaging businesses are going to continue to shrink as doctors and allied health professionals become more familiar with the research.

Wouldn't consider touching this, or trading it, except short.

 

[skc]

Radiology usage is shrinking massively.

Do you have a source for this?

 

[Gringotts Bank]

Do you have a source for this?

Not formal, anecdotal. Also, I'm making a few small assumptions about the current referrers to radiology (GPs, specialists and allied health providers). So long as these referrers:

1- keep up to date with research and
2- want to do the best thing by their patients, then...

..total referrals to radiology should drop quite dramatically. Your wife is a GP, if I remember correctly? She's be aware of the research, which is so powerful it's impossible to argue against.

 

[leyy]

Not formal, anecdotal. Also, I'm making a few small assumptions about the current referrers to radiology (GPs, specialists and allied health providers). So long as these referrers:

1- keep up to date with research and
2- want to do the best thing by their patients, then...

..total referrals to radiology should drop quite dramatically. Your wife is a GP, if I remember correctly? She's be aware of the research, which is so powerful it's impossible to argue against.

everyone is entitled to their own opinion. you know everyone is an expert.

anyways, I have topped up on CAJ for both SMSF and personal account. I was looking to top up some time ago.

This is a well run company with a bright future.

 

[Eily]

Magic of numbers.

Revenue and Profit goes up but mainly due to management fees coming down

Nearly $7m of increased revenue results in -$700k of Net cash from Operating activities.

Why has this stock gone up in value? :1zhelp:

View attachment 49047View attachment 49048

I have also looked at this and I am very concerned. The MD suggesting that recent poor perfomance is due to the Federal Governments MBS review is using hyperbole. I would suggest its more about a poor doctor culture, very ordinary management practices and a Company that has someway to get it governance quality up to standard ?

 

[tinhat]

http://www.abc.net.au/news/2016-01-...e-involving-worlds-largest-3d-printer/7121526

The ABC are reporting that ASIC is investigating the circumstances around 3D Group which went into voluntary administration and whose assets, including intellectual property were sold to a company registered by Johh Condi, Managing Director of Capital Health.

"He [Mr Conidi] assured me that he would make me very rich and that he had the skills to not only take the company to the ASX (Australian Stock Exchange) but to make it very profitable," Mr Simpson alleged.

 

[peter2]

I've added CAJ to both weekly portfolio's today. I was going to wait for the BO >0.30, but the rising TMF and OBV has convinced me to pre-empt the BO. I don't know if pre-empting the BO is a good thing or not for my trading edge as I've not kept the stats.

There seems to be plenty of supply at 0.30 evidenced by the price tails >0.30. Huge volume today.
The probability of higher prices is enough for me to start a medium term trade now.

 

[greggles]

CAJ is coming up as a potential breakout for me. It's been range trading between 25c and 30c for the past 11 months and there has been plenty of accumulation during that time. Today, it is making a move towards 30c and I am getting the feeling that the selling may be drying up a little.

One to watch for a break above 30c.

 

[peter2]

This long consolidation looks likely to end with a break-out soon (>0.325).
Both my volume indicators (OBV, TMF) are rising significantly indicating accumulation.
I've started nibbling once more.

 

[leyy]

This long consolidation looks likely to end with a break-out soon (>0.325).
Both my volume indicators (OBV, TMF) are rising significantly indicating accumulation.
I've started nibbling once more.
View attachment 87696

Spot on peter2.

I have been a medium term holder, so I am pleased to see CAJ break its resistance of 0.325 cents and complete the long consolidation over the last year and close out at 0.335 cents.

It is now at a 2.5 year high, if momentum continues next target is 0.50 cents.

 

[kid hustlr]

Very good call P2 and it continue to look healthy with a nice tight consolidation on low volume @ highs

 

[HelloU]

they did another buy yesterday.....on the face of it the numbers look good for earnings......but...but........anyway should keep SP bubbling along.

 

[rnr]

Price has increased by just over 44% in the last 2 months.

Price has been consolidating over the last 5 bars....is it ready to breakout once again?

 

[peter2]

In the year since the last post the CAJ has been on a ride. Price was stuck in a range for nine months before breaking out >0.265 in Jan 2020. Right before the COVID selloff. Ouch. Price halved and has rallied steadily off the low.

The gov't bans on elective surgery and other non essential medical procedures during the pandemic have hurt all medical service companies (incl IVF - VRT. MVF). As restrictions ease (we all hope they do soon in spite of dictatorial premiers) patient numbers will return to near normal levels eventually. We're all getting older.

Tried to get some CAJ this week but price stayed above my limit price. I'll keep this and VRT, MVF on my radar.

 

[Dona Ferentes]

you would think CAJ was rebounding. A bit. Probably did quite well, considering Covid and lockdowns. Managed to grow volumes and improve margins.

Still making acquisitions : Nov 2020, Direct Radiology; Jan 2020, Fowler Simmons Radiology
Raised $30M in early April 2020 (!) from insto's and SPP

New Management Team (how many stabs at this since listing in 2006?). A lot of acquisitions but integration has always been the challenge. It is said they have spent a lot of time focusing on managing and retaining people - well, der!

The most recent financial results were stronger:
Company highlights and commentary 1H FY21:
• Revenue of $85.3m, an increase of $4.7m or 5.9% on previous corresponding period (pcp)
• Statutory EBITDA of $22.6m, an increase of $6.6m or 41.4% on pcp
• Operating EBITDA of $26.6m, an increase of $8.9m or 50.1% on pcp
• Operating Margin of 31.1% up from 22.0% for pcp
• Statutory NPAT of $6.2m, an increase of $3.5m or 131.6% on pcp
• Interim dividend payment maintained at 0.5 cps fully franked

The Company plans to continue organic growth via greenfield and brownfield developments. Strategic priorities for the current year include:
• Ongoing investment in systems, people, and capability to enhance our referrer relationships
• Continue to measure and enhance the patient experience
• Review of information and communication technology in support of clinics, referrers and patients

Five year chart: (but the previous 5 years was a mountain range ... over $1 in 2015)

(NH, DNH)

 

[investtrader]

Nice trend on Weekly. Very strong fundamentals and good value.

 

[divs4ever]

CAJ is my pick for the February comp.

i have a small top up order currently in the market ( and close the the market action )


i am still calmly trying to accumulate health-care related stocks

looks like the share price will trend down early in the month

but USUALLY goes ex-div. in early March

GLAH

 

[System]

On December 23rd, 2024, Capitol Health Limited (CAJ) was removed from the ASX's Official List in accordance with Listing Rule 17.11, following implementation of the scheme of arrangement between CAJ and its shareholders in connection with the acquisition of all the issued capital in CAJ by Internal Diagnostics Limited.

 

[divs4ever]

yes the holding is now converted to IDX ( for better or worse )

GLAH